财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(MRTX)
公司资讯
finviz | 2022年09月10日 21:12
Is There An Opportunity With Mirati Therapeutics, Inc.'s (NASDAQ:MRTX) 30% Undervaluation?
finviz | 2022年09月08日 21:21
Mirati's Adagrasib Shows Promising Efficacy In KRAS Mutated Colorectal Cancer
finviz | 2022年09月08日 06:05
Mirati Therapeutics Presents Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer
finviz | 2022年09月03日 06:07
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finviz | 2022年09月02日 23:31
Mirati (MRTX) Up 5.3% Since Last Earnings Report: Can It Continue?
finviz | 2022年09月01日 04:30
Mirati Therapeutics to Participate in Two Upcoming Healthcare Conferences
finviz | 2022年09月01日 04:09
Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost
finviz | 2022年09月01日 00:12
Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study
finviz | 2022年08月08日 18:20
Growth Investors: Industry Analysts Just Upgraded Their Mirati Therapeutics, Inc. (NASDAQ:MRTX) Revenue Forecasts By 16%
finviz | 2022年08月06日 20:13
We Think Mirati Therapeutics (NASDAQ:MRTX) Can Afford To Drive Business Growth
finviz | 2022年08月05日 04:30
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finviz | 2022年08月05日 01:17
Mirati (MRTX) Q2 Loss Narrower Than Expected, Sales Beat
finviz | 2022年08月04日 06:15
Mirati (MRTX) Reports Q2 Loss, Tops Revenue Estimates
finviz | 2022年08月04日 04:01
Mirati Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
finviz | 2022年07月21日 04:30
Mirati Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Updates
finviz | 2022年07月01日 01:08
Biotech ETF Tops in June: 5 Stocks That Outperform
首页
 
上页
下页